ATHE

Alterity Therapeutics Ltd (ATHE)

US
$ 4.25-5.76%

Price Chart

Key Statistics

Market Cap
$ 51.37M
P/E Ratio
0.00
Revenue (TTM)
$ 3.72M
Volume
160.48K
52W High
$ 5.87
52W Low
$ 1.00
Dividend Yield
0.00%
Beta
0.70

Technicals

50-Day MA
3.6544
200-Day MA
2.3339
52 Week High
5.87
52 Week Low
1.001

About ATHE

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Au.

Employees
10
Headquarters
Melbourne, VIC
CEO
Mr. Geoffrey Paul Kempler B.Sc.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg